LAMPRENE vs MYCOBUTIN

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. LAMPRENE and MYCOBUTIN are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LAMPRENE	MYCOBUTIN
Rating	70/100	64/100
Pharmacy pays	—	~$275.36 /30
Type	RX	RX
Active ingredient	CLOFAZIMINE	RIFABUTIN
Manufacturer	Novartis	Pfizer
Dosage forms	Capsule	Capsule
Drug class	—	—
Boxed warning	None	None
Treats	Mycobacterium Avium-Intracellulare Infection, Borderline Leprosy, Lepromatous Leprosy	Pulmonary Tuberculosis, Mycobacterium Avium-Intracellulare Infection

lamprene mycobutin

Rating

70/100

64/100

Pharmacy pays

—

~$275.36 /30

Type

Active ingredient

CLOFAZIMINE

RIFABUTIN

Manufacturer

Novartis

Pfizer

Dosage forms

Capsule

Drug class

—

Boxed warning

None

Treats

Mycobacterium Avium-Intracellulare Infection, Borderline Leprosy, Lepromatous Leprosy

Pulmonary Tuberculosis, Mycobacterium Avium-Intracellulare Infection

Frequently asked questions

Which is better-rated, Lamprene or Mycobutin?

By our independent rating, Lamprene scores higher — 3.5 vs 3.2 out of 5 for Mycobutin. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Lamprene and Mycobutin?

Lamprene contains Clofazimine, while Mycobutin contains Rifabutin — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.